Bruker 公司

最新新闻

• 评级变动
  Analysts Offer Insights on Healthcare Companies: MannKind (MNKD), Bruker (BRKR) and BrightSpring Health Services, Inc. (BTSG)
  TipRanks · 2026/7/27
• 评级变动
  Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $70
  \u5e02\u573a\u8d44\u8baf · 2026/6/29
• 评级变动
  Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $60
  \u5e02\u573a\u8d44\u8baf · 2026/6/24
• 评级变动
  BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $65
  \u5e02\u573a\u8d44\u8baf · 2026/6/2
• 评级变动
  J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $65
  \u5e02\u573a\u8d44\u8baf · 2026/6/8
• Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $58
  \u5e02\u573a\u8d44\u8baf · 2026/8/25
• 评级变动
  A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $44 to $53
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  Stifel Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $45
  \u5e02\u573a\u8d44\u8baf · 2026/5/9
• BofA Securities Maintains Bruker Corp(BRKR.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/6
• 评级变动
  Goldman Sachs Maintains Bruker Corp(BRKR.US) With Sell Rating, Raises Target Price to $40
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• 评级变动
  Citi Maintains Bruker Corp(BRKR.US) With Hold Rating, Cuts Target Price to $53
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $45
  \u5e02\u573a\u8d44\u8baf · 2026/4/14
• Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $72
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $70
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  Wolfe Research Initiates Bruker Corp(BRKR.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/2
• 评级变动
  Goldman Sachs Maintains Bruker Corp(BRKR.US) With Sell Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/7/27
• J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $60
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  Citi Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $60
  \u5e02\u573a\u8d44\u8baf · 2026/7/8
• 评级变动
  TD Cowen Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $60
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• Leerink Partners Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $80
  \u5e02\u573a\u8d44\u8baf · 2026/9/29

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。